NFKB1 and diabetes mellitus: This inflammatory milieu interacts with the characteristic metabolic abnormalities of diabetes: persistent hyperglycemia activates the polyol pathway and promotes the formation of advanced glycation end products (AGEs), which activate the NF-κB signaling pathway through RAGE receptors, leading to excessive ROS production and endothelial dysfunction.